Phuong Khanh Morrow

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Eric M. Green, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Phuong Khanh Morrow:

Company Role Class Num Shares Value Price $ Report Date Ownership
Lantheus Holdings, Inc. Director Common Stock 3,100 $321,284 $103.64 14 May 2025 Direct
CRISPR Therapeutics AG Chief Medical Officer Common Shares 4,411 $275,700 $62.50 24 May 2023 Direct
CRISPR Therapeutics AG Chief Medical Officer Restricted Stock Units 20,812 23 May 2023 Direct
CRISPR Therapeutics AG Chief Medical Officer Stock Option (Right to Buy) 16,667 13 Oct 2023 Direct
Lantheus Holdings, Inc. Director Stock Option (right to buy) 4,543 14 May 2025 Direct

Insider Reports Filed by Phuong Khanh Morrow

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LNTH Lantheus Holdings, Inc. 14 May 2025 2 $0 4 Director 16 May 2025, 16:41
LNTH Lantheus Holdings, Inc. 07 Feb 2025 1 $0 4/A Director 12 Feb 2025, 17:15
LNTH Lantheus Holdings, Inc. 01 Feb 2025 0 $0 3 Director 07 Feb 2025, 18:34
CRSP CRISPR Therapeutics AG 13 Oct 2023 1 $0 4 Chief Medical Officer 17 Oct 2023, 17:52
CRSP CRISPR Therapeutics AG 23 May 2023 3 -$166,555 4 Chief Medical Officer 25 May 2023, 17:35
CRSP CRISPR Therapeutics AG 10 Mar 2023 2 $0 4 Chief Medical Officer 14 Mar 2023, 17:44
CRSP CRISPR Therapeutics AG 07 Oct 2022 1 $0 4 Chief Medical Officer 12 Oct 2022, 17:41
CRSP CRISPR Therapeutics AG 23 May 2022 2 $0 4 Chief Medical Officer 24 May 2022, 17:55
CRSP CRISPR Therapeutics AG 23 May 2022 0 $0 3 Chief Medical Officer 23 May 2022, 17:41